Fragment-based drug discovery of potent and selective MKK3/6 inhibitors

Mark Adams1, Toshitake Kobayashi2, J David Lawson3

  • 1Medicinal Chemistry, Takeda California Inc., 10410 Science Center Drive, San Diego, CA 92121, United States.